ScoreWhy is Lepu Medical Technology (Beijing) Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -5.35% and Operating profit at -21.96% over the last 5 years
2
With a growth in Net Profit of 176.18%, the company declared Very Positive results in Sep 25
- The company has declared positive results in Jan 70 after 8 consecutive negative quarters
- PRE-TAX PROFIT(Q) At CNY 355.73 MM has Grown at 144.34%
- NET PROFIT(Q) At CNY 292.51 MM has Grown at 140.08%
- RAW MATERIAL COST(Y) Fallen by -24.46% (YoY)
3
With ROE of 1.75%, it has a expensive valuation with a 2.07 Price to Book Value
- Over the past year, while the stock has generated a return of 39.69%, its profits have fallen by -73%
- At the current price, the company has a high dividend yield of 1.7
4
Market Beating Performance
- The stock has generated a return of 39.69% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.17%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Lepu Medical Technology (Beijing) Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Lepu Medical Technology (Beijing) Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lepu Medical Technology (Beijing) Co., Ltd.
36.14%
0.00
49.95%
China Shanghai Composite
15.45%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-5.35%
EBIT Growth (5y)
-21.96%
EBIT to Interest (avg)
8.86
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
0.34
Tax Ratio
1.50%
Dividend Payout Ratio
207.34%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.06%
ROE (avg)
10.64%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
118
Industry P/E
Price to Book Value
2.07
EV to EBIT
85.81
EV to EBITDA
31.65
EV to Capital Employed
1.95
EV to Sales
5.78
PEG Ratio
NA
Dividend Yield
1.71%
ROCE (Latest)
2.27%
ROE (Latest)
1.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
PRE-TAX PROFIT(Q)
At CNY 355.73 MM has Grown at 144.34%
NET PROFIT(Q)
At CNY 292.51 MM has Grown at 140.08%
RAW MATERIAL COST(Y)
Fallen by -24.46% (YoY
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Lepu Medical Technology (Beijing) Co., Ltd.
Pre-Tax Profit
At CNY 355.73 MM has Grown at 144.34%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 292.51 MM has Grown at 140.08%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -24.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
